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Background: Anemia in pregnancy in malaria endemic areas is a public health challenge that 
has contributed either directly or indirectly to maternal morbidity and mortality in our environ-
ment. Anemia and malaria during pregnancy are highly preventable and treatable.
Objective: The aim of this study is to assess the prevalence of anemia in asymptomatic malaria 
parasitemic women at first antenatal visit in a tertiary hospital facility.
Method: The study was conducted at the antenatal clinic of the University of Calabar Teach-
ing Hospital, Calabar, Nigeria over a three-month period. Five hundred and forty-five pregnant 
women were recruited after obtaining an informed consent. A structured questionnaire was 
administered to each participant and two thin and thick blood films were used to identify the 
malaria parasites and estimate density. The average of two packed cell volumes at booking was 
determined using two capillary tubes and read from a Hawksleys microhematocrit reader.
Results: A total of 545 pregnant women participated in the study. The mean ages of primi-
gravidas and multigravidas were 21.4 ± 3.1 and 24.3 ± 4.0 years. Two hundred and ninety 
(53.2%) were primigravidas while 255 (46.8%) were multigravidas. The parasite density in 
primigravidas was 1297 ± 1234 while that for multigravidas was 661 ± 497 (t = 7.7, P , 0.001). 
The prevalence of anemia in the study population was 59.6%. There was no statistically 
significant difference in the prevalence of anemia among the primigravidas (60.3%) and the 
multigravidas (58.8%) (χ2 = 1.3, P = 0.08). There was a statistically significant association 
between severity of parasitemia and degree of anemia (χ2 = 441.1, P , 0.001). There was a 
statistically significant association between antimalarials use before booking and severity of 
parasitemia (χ2 = 36.52, P , 0.001).
Conclusion: Anemia at first antenatal booking was significantly associated with malaria 
parasitemia. Routine screening for anemia and malaria parasites at booking, prompt parasite 
clearance, use of intermittent preventive treatment (IPT) during pregnancy and correction 
of anemia can reduce the prevalence of malaria related anemia and obstetric complications 
associated with it.
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Introduction
The importance of a good hemoglobin concentration during pregnancy for both the 
woman and the growing fetus cannot be overemphasized. Being a driving force for 
oxygen and nutrients for mother and fetus, a reduction below acceptable levels can 
be detrimental to both. A hemoglobin concentration below 11.0 g/dL or packed cell International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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  volume (PCV) of less than 33.0% is regarded as   anemia 
  during pregnancy by the World Health Organization 
(WHO).1,2 This value is important and should be adopted 
as a standard even in our developing countries in order that 
we do not   under-play the burden of anemia in pregnancy.3 
Anemia is said to be the commonest medical condition in 
pregnancy with a prevalence of 50% worldwide.4 Recent esti-
mates in the developing countries including Nigeria put the 
  prevalence at 60% in pregnancy and about 7% of the women 
are said to be severely anemic.4,5 Most of those affected are 
the primigravidas and grandmultiparas.6 Excessively rapid 
destruction of red blood cells, bleeding during pregnancy and 
inadequate hematopoeisis are the three major causes. Severe 
malaria parasitemia appear to be a leading cause especially in 
our environment.2,3,6,7 Malaria causes increased hemolysis of 
parasitized red blood cells. The degree of hemolysis depends 
on the burden of parasites.8,9 It is important to state that aside 
from malaria, helminthiases as well as nutritional factors also 
contribute variously to anemia during pregnancy.10 Although 
adults living in endemic areas acquire protective immunity 
against developing severe malaria, they become more sus-
ceptible especially when they become pregnant.9 In areas 
with stable malaria like Cross River State of Nigeria, the 
vast majority of infestations with Plasmodium falciparum in 
pregnancy remain asymptomatic, undetected and untreated. 
The high prevalence of anemia and malaria parasitemia in 
the general population, especially in malaria endemic areas, 
and the depression of immunity in pregnancy, call for assess-
ment of the prevalence of malaria parasitemia and associated 
morbidity. The aim of this study is to assess the prevalence of 
anemia in malaria parasitemic women during first antenatal 
booking visit in a tertiary hospital in a low resource setting. 
It is hoped that the results of this study will assist in the 
development of strategy to reduce adverse effects associated 
with this medical problem in obstetrics in our society.
Method
This prospective observational study was conducted at the 
University of Calabar Teaching Hospital, Calabar, Nigeria 
over a three-month period (April to June). This period is 
characterized by heavy rainfall and malaria transmission. 
The teaching hospital is the only tertiary health institu-
tion in Cross River State (Niger Delta region) of Nigeria. 
The state has a population of about 3million people and 
female literacy level of 62.0%. It has a tropical rain forest 
and is holoendemic to malaria. Approval for this research 
was given by the Research and Ethics Committee of the 
hospital. A structured questionnaire was administered, 
by the authors, to all pregnant women who booked for 
antenatal care at the University of Calabar Teaching 
Hospital, Calabar, after an unwritten informed consent 
was obtained. Those who refused to give consent, HIV-
positive women, and those with symptomatic infections 
were excluded from the study. All antenatal bookings 
in the hospital are carried out in one day of the week. 
Information obtained included age, parity, social status, 
and malaria treatment prior to the visit. The method of 
obtaining the specimen was adequately explained to the 
pregnant women. After aseptic procedure, a sterile lancet 
was used to pierce the palmar surface of the thumb. Two 
capillary tubes, labeled for each patient, were filled with 
blood and one end sealed with a plasticin gum for deter-
mination of packed cell volume at booking. This was 
to ensure that the average of the two values obtained is 
used for calculation. Several samples were assembled in 
the Centrifuge (hematocrit machine) and spinned at 5000 
revolutions per minute for 5 minutes. When the machine 
had rotated to a halt the cover was opened and the PCV 
read from a Hawksley microhematocrit reader. Anemia 
was considered as a packed cell volume below 33% in line 
with the World Health Organization recommendation.3,6 
Anemia was classified as mild (pcv 24.0%–,32.0%) or 
moderate (pcv 18.0%–,24.0%) or severe (pcv , 18.0%). 
Two glass slides were then labeled for each patient. Thin 
and thick blood films were prepared and stained with 
Giemsa stain. The slides were read under oil immersion 
with a 100x objective magnification. Parasite enumeration 
was done using the WHO approved method.13 Quality 
control was ensured using standard positive and negative 
films as well as standard operation procedures. Where 
there were doubts, films were cross-examined by a senior 
microscopist.
Minimum sample size of 464 women for the study was 
calculated from an earlier pilot study by the authors based on 
a prevalence of malaria parasitemia of 54.0% in 40 pregnant 
women at first antenatal visit. The findings of this study 
were subjected to statistical analysis using EPI – Info 2002 
Statistical software of the Centre for Disease Control and 
  Prevention, Atlanta, USA. A P-value of ,0.05 was con-
sidered significant. Quantification of parasite density (per 
deciliter) used in this study is as follows: lower , 1,000; 
intermediate 1,000–2,999; higher . 3,000 parasites per deci-
liter. All those with malaria parasitemia were treated based 
on the Nigerian National Antimalarial Treatment Guidelines 
followed with two doses of sulfadoxine-pyrimethamine as 
intermittent preventive treatment (IPT).International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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Results
A total of 545 pregnant women participated in the study. 
The mean ages of primigravidas and multigravidas were 
21.4 ± 3.1 and 24.3 ± 4.0 years. Most of the participants were 
literate. Two hundred and ninety (53.2%) were primigravidas 
while 255 (46.8%) were multigravidas. The gestational ages 
at first booking ranged from 8 to 37 weeks for all parities. 
The mean booking gestational age of the primigravidas was 
16 ± 4.7 weeks while that of the multigravidas was 22.6 ± 5.5 
weeks (t = 13.6, P , 0.001). The parasite density in primi-
gravidas was 1297 ± 1234 while that for multigravidas was 
661 ± 497 (t = 7.7, P , 0.001).
The prevalence of anemia in the study population was 
59.6%. There was no statistically significant difference in the 
prevalence of anemia among the primigravidas (60.3%) and 
the multigravidas (58.8%) (χ2 = 1.3, P = 0.08).
All participants who had no parasitemia had normal 
packed cell volume (PCV). One hundred and sixty-seven 
(58.4%) participants who had mild parasitemia were mildly 
or moderately anemic; nobody in this group had severe 
anemia, while the rest (41.6%) had normal hemogram. Simi-
larly, none of the intermediate parasitemic participants had 
severe anemia (Table 1); 76 (33.3%) had normal PCV while 
152 (66.7%) had mild to moderate anemia. The majority 
(66.7%) of those who had severe parasitemia were severely 
anemic, 2 (33.3%) had mild to moderate anemia while none 
had normal hemogram. There was a statistically significant 
association between severity of parasitemia and degree of 
anemia (χ2 = 441.1, P , 0.001).
Two hundred and eighty (51.4%) of participants took 
  antimalarial before first booking at the antenatal clinic. 
Of these, 25 (8.9%) had no parasitemia. All those who did not 
take antimalarials before booking had parasitemia. There was 
a statistically significant association between the use of anti-
malarials before booking and parasite clearance (χ2 = 24.8, 
P , 0.001). Those who used antimalarials before booking were 
more likely to be free from malaria parasitemia (Table 2). 
The use of antimalarials before booking also affected the 
degree of malarial parasitemia: the parasitemia among those 
who took antimalarials was more likely to be mild while 
the parasitemia among those who did not take antimalarials 
was more likely to be intermediate or severe. There was a 
statistically significant association between antimalarials 
use before booking and severity of parasitemia (χ2 = 36.52, 
P , 0.001) (Table 3).
Discussion
Assessment of anemia during pregnancy is important because 
it directly or indirectly contributes to the high maternal and 
perinatal morbidity and mortality seen in Nigeria.12 It also 
affords one the opportunity to institute interventions to pre-
vent complications especially when carried out at booking 
visit. It is a known fact that malaria is an under-recognized 
cause of anemia in pregnancy in endemic areas like ours and 
is usually asymptomatic.2,8 Malaria may cause or aggravate 
anemia.3,6 This may follow hemolysis of parasitized red blood 
cells, increased demand for folates in pregnancy as well as 
hypersplenism.6,9 The very high prevalence of malaria para-
sitemia in this study (95.4%) shows how enormous it could 
contribute to anemia during pregnancy.8 This prevalence is 
far higher than the 16% reported from Southeastern Nigeria.13 
However, the report from Abakiliki, South Eastern Nigeria 
targeted women in their third trimester that may have had 
significant parasite clearance with effective antimalarial 
drugs prior to their enrollment into the study.13 Both malaria 
and anemia in pregnancy therefore pose a serious public 
health challenge.
The reported incidence of anemia is between 30%–60% 
in pregnancy.4 The prevalence of anemia at first antenatal 
Table 1 cross tabulation of severity of parasitemia with packed 
cell volume
Severity of  
parasitemia
PCV # 20 21–32 $33 Total
no parasite 0 0 25 (100%) 25 (100%)
Lower 0 167 (58.4%) 119 (41.6%) 286 (100%)
Intermediate 0 152 (66.7%) 76 (33.3%) 228 (100%)
Higher 4 (66.7%) 2 (33.3%) 0 6 (100%)
Total 4 (0.7%) 321 (58.9%) 220 (40.4%) 545 (100%)
Notes: χ2 = 441.1, P , 0.001.
Table 2 Cross tabulation of anti-malaria use before first booking 
with parasitemia
Anti-malaria  
use 
Parasitemia 
Yes
 
No
Total
Yes 255 (91.1%) 25 (8.9%) 280 (100%)
no 265 (100%) 0 265 (100%)
Total 520 (95.4%) 25 (4.6%) 545 (100%)
Notes: χ2 = 24.8, P , 0.001.
Table  3  cross  tabulation  of  anti-malaria  use  with  degree  of 
parasitemia
Anti-malaria 
use
Parasitemia 
lower 
 Intermediate  Higher  Total
Yes 175 (68.6%) 80 (31.4%) 0 255 (100%)
no 112 (42.3%) 147 (55.5%) 6 (2.3%) 265 (100%)
Total 287 (55.2%) 227 (43.7%) 6 (1.2%) 520 (100%)
Notes: χ2 = 36.5, P , 0.001.International Journal of Women’s Health 2010:2 submit your manuscript | www.dovepress.com
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visit in this study of 59.6% was lower than the 71% reported 
from Lagos,2 67.4% reported from Enugu,14 and 66.0% 
reported from Burkina Faso15 but higher than that reported 
from Ibadan, Nigeria, and Greytown in South Africa.1,16 The 
probable explanation is that majority of the pregnant women 
in this study were literate and are gainfully employed, hence 
their nutritional status is probably better. The high prevalence 
of anemia in this study is not acceptable, given the fact that 
malaria is preventable and treatable. Malaria cause anemia 
mostly in the second trimester of pregnancy when there is 
accelerated fetal growth and may develop suddenly in severe 
parasitaemia that may persist into the third trimester.7 Anemia 
in pregnancy has been shown to be commoner in the second 
trimester especially in severe parasitemia as seen in this 
study which agrees with previous reports.2,5,8 In this study 
most booking visits were made in the second trimester when 
parasitemia tends to be highest.17
Mean parasite density in primigravidas was significantly 
higher than in multigravidas. This is in agreement with the 
fact that this group of pregnant women has lower immunity to 
malaria. Consequently, anemia will be expected to be severer 
in them.6,9 However, a closer look at Table 2 will show that 
the prevalence of anemia was higher in multigravidas than 
primigravidas. This could be explained by the fact that the 
primigravidas booked at a significantly lower gestational age 
than the multigravidas (see Table 1). This is in agreement with 
previous studies.2,17 The implication is that the multigravidas 
waited until parasitemia had adversely affected them before 
booking.
All the women who had severe parasitemia had anemia. 
The severity of anemia in this study could be related to the 
parasite density. Thus, the higher the parasite density, the 
severer the anemia tends to be.
It was observed that some of those who came for booking 
at the teaching hospital had various forms of antimalarial 
drugs either from health care providers or over the counter. 
There was a statistically significant association between 
antimalarials use before booking and severity of parasitemia. 
The efficacies of the ingested antimalarial medications can 
not be ascertained because of high volume of counterfeit 
and fake antimalarial drugs in circulation.18,19 The interval 
from ingestion of antimalarial drugs to first visit could not 
be ascertained in majority of cases. All those who did not 
take antimalarial drugs were parasitemic, while 91.1% of 
those who took medications were parasitemic. It therefore 
means that antimalarial chemotherapy used had effect in 
reducing parasite density.5,6 This can also modulate the effect 
on anemia in pregnancy.
Conclusion
Anemia in pregnancy is associated with malaria parasitemia. 
The severity of anemia is directly correlated with the den-
sity of parasitemia, particularly amongst the primigravidas. 
Antimalarial therapy that clears the parasitemia appears to 
have better effect on the level of anemia.
It is therefore recommended that comprehensive preven-
tive strategy including intermittent preventive treatment of 
malaria in pregnancy, good nutrition and effective use of 
insecticide treated bed nets be encouraged among pregnant 
women in endemic regions.
Parasite clearance at booking using safe and effective 
antimalarial agents should be recommended for all pregnant 
women especially primigravidas to reduce the incidence and 
complications associated with anemia.
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